We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+5.08%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$836M
AUM Growth
+$186M
Cap. Flow
+$173M
Cap. Flow %
20.65%
Top 10 Hldgs %
29.89%
Holding
597
New
223
Increased
13
Reduced
17
Closed
170

Sector Composition

Rank Sector Weight
1 Healthcare 33.03%
2 Financials 12.76%
3 Technology 11.06%
4 Industrials 8.14%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRHC
126
DELISTED
Cohn Robbins Holdings Corp.
CRHC
$1.97M 0.24%
200,000
EQRX
127
DELISTED
EQRx, Inc. Common Stock
EQRX
$1.96M 0.23%
+190,315
New +$1.95M
NSTC
128
DELISTED
Northern Star Investment Corp. III
NSTC
$1.96M 0.23%
+199,986
New +$1.96M
FRGE
129
DELISTED
Forge Global Holdings
FRGE
$1.95M 0.23%
13,333
HIII
130
DELISTED
Hudson Executive Investment Corp. III Class A Common Stock
HIII
$1.95M 0.23%
+199,990
New +$1.96M
NRGV icon
131
Energy Vault
NRGV
$633M
$1.95M 0.23%
+199,992
New +$1.95M
AKIC
132
DELISTED
Sports Ventures Acquisition Corp. Class A Ordinary Shares
AKIC
$1.94M 0.23%
200,000
MIT
133
DELISTED
Mason Industrial Technology, Inc.
MIT
$1.93M 0.23%
+199,995
New +$1.94M
MSDA
134
DELISTED
MSD Acquisition Corp. Class A Ordinary Shares
MSDA
$1.92M 0.23%
+228,378
New +$2.26M
ELEV
135
DELISTED
Elevation Oncology
ELEV
$1.9M 0.23%
+140,000
New +$1.73M
LENZ
136
LENZ Therapeutics
LENZ
$168M
$1.84M 0.22%
+8,571
New +$1.49M
PRAX icon
137
Praxis Precision Medicines
PRAX
$10.1B
$1.83M 0.22%
+6,667
New +$2.39M
LFMD icon
138
LifeMD
LFMD
$172M
$1.79M 0.21%
152,174
THRY icon
139
Thryv Holdings
THRY
$108M
$1.79M 0.21%
+50,000
New +$1.41M
IPSC icon
140
Century Therapeutics
IPSC
$361M
$1.76M 0.21%
+60,000
New +$1.52M
ACRS icon
141
Aclaris Therapeutics
ACRS
$869M
$1.76M 0.21%
+100,000
New +$2.27M
ME
142
DELISTED
23andMe Holding Co
ME
$1.75M 0.21%
7,500
BTAI icon
143
BioXcel Therapeutics
BTAI
$27.8M
$1.74M 0.21%
+3,750
New +$2.04M
HHR
144
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
$1.7M 0.2%
+40,000
New +$1.54M
CVRX icon
145
CVRx
CVRX
$63.4M
$1.68M 0.2%
+60,000
New +$1.68M
ZETA icon
146
Zeta Global
ZETA
$6.69B
$1.68M 0.2%
+200,000
New +$1.69M
LSPD icon
147
Lightspeed Commerce
LSPD
$1.35B
$1.67M 0.2%
+20,000
New +$1.41M
ALDX icon
148
Aldeyra Therapeutics
ALDX
$93.5M
$1.66M 0.2%
+146,584
New +$1.76M
EGLE
149
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$1.66M 0.2%
+35,000
New +$1.59M
IAS
150
DELISTED
Integral Ad Science
IAS
$1.65M 0.2%
+80,000
New +$1.65M

Similar funds

Monashee Investment Management's Q2 2021 Portfolio in Review

As of Q2 2021, Monashee Investment Management held 597 positions worth $836M, up 29% from $650M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Monashee Investment Management deployed $173M of net new capital in Q2 2021, opening 223 new positions and adding to 13 existing holdings. Its largest new stake was ATI Physical Therapy, Inc.: 45,248 shares worth $21.6M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 27% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Beam Therapeutics, an estimated $13.5M trimmed.

  • Monashee Investment Management's largest Q2 2021 buy was ATI Physical Therapy, Inc.: 45,248 shares worth $21.6M.
  • Monashee Investment Management added most to PLAYSTUDIOS Inc in Q2 2021, an estimated $14.5M increase.
  • Monashee Investment Management's biggest Q2 2021 reduction was Beam Therapeutics, cutting an estimated $13.5M.
  • Monashee Investment Management fully exited Sotera Health in Q2 2021, selling an estimated $8.74M.
  • Monashee Investment Management's ten largest holdings make up 30% of its $836M portfolio in Q2 2021.
  • Monashee Investment Management opened 223 new positions and closed 170 in Q2 2021.
  • Monashee Investment Management's portfolio value rose 29% quarter-over-quarter to $836M.

Based on Monashee Investment Management's 13F filing for Q2 2021, filed 12 Aug 2021.